a) m. sphincter pupillae b) m. dilatator pupillae c) m. ciliaris d) m. detrusor
a) decrease the activity of PLC – phospholipase C b) decrease the activity of AC - adenyl cyclase c) increase the activity of PLC – phospholipase C d) increase the activity of AC- adenyl cyclase
a) ↓ activity of AC, ↓ cAMP, ↑ activity of K+ channels b) ↑ activity of phospholipase C, ↑ IP3 , ↑ DAG, ↑ Ca2+ c) ↑ activity of K+ channels, ↓ Ca2+ d) ↑ activity of AC, ↑ cAMP
a) oxybutynin - asthma b) labetalol – hypertensive crisis c) phenoxybenzamine – erectile dysfunction d) butylscopolamine – opthalmologic examination of retina
a) acetylcholine b) arecoline c) atropine d) apraclonidine
a) neostigmine b) atropine c) mirabegron d) varenicline
a) atropine b) atropine + pralidoxime c) physostigmine d) glucagon + dobutamine
a) esmolol b) nadolol c) bisoprolol d) carvedilol
a) Yes b) No
a) 2 – 5 μg/kg/min b) 5-10 μg/kg/min c) 10-30 μg/kg/min d) more than 30 μg/kg/min
a) higher risk of metabolic side effects b) lower incidence of bronchoconstriction c) antagonistic effects on alpha adrenoreceptors d) aj CNS adverse effects
a) it has intrinsic activity but no affinity for β adrenoreceptors b) sa it binds to a site different to that of an agonist, e.g. epinephrine c) it has affinity but no activity for β adrenoreceptors d) sa it binds on 2 receptors, but have opposite effects than agonist of β adrenoreceptors
a) pilocaprine b) atropine c) timolol d) betaxolol